Neuroprotective Properties of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) and its Lipid Ligands

被引:97
作者
Fidaleo, Marco [1 ]
Fanelli, Francesca [2 ,3 ]
Ceru, Maria Paola [3 ,4 ]
Moreno, Sandra [3 ]
机构
[1] IRCCS S Lucia Fdn, I-00143 Rome, Italy
[2] Univ Campus Biomed, I-00128 Rome, Italy
[3] Univ Roma Tre, Dept Sci, I-00146 Rome, Italy
[4] Univ Aquila, Dept Life Hlth & Environm Sci, I-67100 Coppito, AQ, Italy
关键词
Brain; catalase; fatty acyl-CoA beta-oxidation; lipid signalling; neurodegeneration; neuroprotection; OEA; oxidative stress; PEA; peroxisome proliferator activated receptor; RETINOID-X-RECEPTOR; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; NF-KAPPA-B; INHIBIT INFLAMMATORY RESPONSES; NUCLEAR HORMONE-RECEPTORS; ACID AMIDE HYDROLASE; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; FATTY-ACID;
D O I
10.2174/0929867321666140303143455
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Signalling lipids are known to control a wide array of cellular processes, including cell proliferation, apoptosis, migration, and energy metabolism. Fatty acids and their derivatives, eicosanoids, phosphoinositides, sphingolipids, some cannabinoid-like molecules bind and activate nuclear receptors, including peroxisome proliferator-activated receptors (PPARs). This subfamily of transcription factors comprises three isotypes - PPAR alpha (NR1C1), PPAR beta/delta (NR1C2), PPAR gamma (NR1C3) - which bind to specific DNA response elements, as heterodimers with retinoid X receptors. PPAR activity is modulated by post-translational modifications and cofactors, towards which they show differential affinity. The three PPARs mutually interact, being integrated in a complex system, leading to the concept of a "PPAR triad". Nevertheless, the isotypes also show distinct actions on cellular physiology and partially different tissue, ligand and target gene specificities. In the brain, while the functions of PPAR gamma and its ligands are being thoroughly investigated, the actual and potential roles of PPAR alpha and beta/delta are far from being clarified. PPAR appears especially intriguing, since it is selectively expressed in certain brain areas and neuronal/glial populations, and modulates antioxidant responses, neurotransmission, neuroinflammation, neurogenesis, and glial cell proliferation/differentiation. This receptor and its endogenous ligands, including oleoylethanoloamide (OEA) and palmitoylethanolamide (PEA), are involved in physiological and pathological responses, such as satiety, memory consolidation, and modulation of pain perception. The protective role of PPAR alpha agonists in neurodegenerative diseases and in neuropsychiatric disorders makes manipulation of this pathway highly attractive as therapeutic strategy for neuropathological conditions. In this review, we focus on the pleiotropic functions of PPAR alpha and its lipid ligands in the nervous tissue, devoting special attention to neuroprotection.
引用
收藏
页码:2803 / 2821
页数:19
相关论文
共 50 条
  • [1] THE ROLE OF ENDOGENOUS AND EXOGENOUS LIGANDS FOR THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPAR-α) IN THE REGULATION OF INFLAMMATION IN MACROPHAGES
    Crisafulli, Concetta
    Cuzzocrea, Salvatore
    SHOCK, 2009, 32 (01): : 62 - 73
  • [2] Peroxisome Proliferator-Activated Receptor Alpha (PPARα), a Key Regulator of Lipid Metabolism in Avians
    Navidshad, B.
    Royan, M.
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2016, 26 (04): : 303 - 308
  • [3] The peroxisome proliferator-activated receptor α (PPARα):: role in hepatocarcinogenesis
    Gonzalez, FJ
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 193 (1-2) : 71 - 79
  • [4] Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study
    Corton, J. Christopher
    Cunningham, Michael L.
    Hummer, B. Timothy
    Lau, Christopher
    Meek, Bette
    Peters, Jeffrey M.
    Popp, James A.
    Rhomberg, Lorenz
    Seed, Jennifer
    Klaunig, James E.
    CRITICAL REVIEWS IN TOXICOLOGY, 2014, 44 (01) : 1 - 49
  • [5] Peroxisome proliferator-activated receptors (PPAR). Antiproliferative properties
    Hojka, Anna
    Rapak, Andrzej
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2011, 65 : 404 - 413
  • [6] Astaxanthin as a Peroxisome Proliferator-Activated Receptor (PPAR) Modulator: Its Therapeutic Implications
    Choi, Chang-Ik
    MARINE DRUGS, 2019, 17 (04):
  • [7] Peroxisome proliferator-activated receptor-γ (PPAR-γ) ligands as potential therapeutic agents to treat arthritis
    Giaginis, Costas
    Giagini, Athina
    Theocharis, Stamatios
    PHARMACOLOGICAL RESEARCH, 2009, 60 (03) : 160 - 169
  • [8] Neuroprotective Efficacy of the Peroxisome Proliferator-Activated Receptor-γ Ligand in Chronic Cerebral Hypoperfusion
    Sayan-Ozacmak, Hale
    Ozacmak, V. Haktan
    Barut, Figen
    Jakubowska-Dogru, Ewa
    CURRENT NEUROVASCULAR RESEARCH, 2011, 8 (03) : 190 - 199
  • [9] Pancreatic islet response to hyperglycemia is dependent on peroxisome proliferator-activated receptor alpha (PPARα)
    Bihan, H
    Rouault, C
    Reach, G
    Poitout, V
    Staels, B
    Guerre-Millo, M
    FEBS LETTERS, 2005, 579 (11) : 2284 - 2288
  • [10] Induction of the expression of the peroxisome proliferator-activated receptor alpha (PPARα) by clofibrate in jerboa tissues
    Amsaguine-Safir, S
    Bianchi, A
    Collet, P
    Huin-Schohn, C
    Jeanvoine, A
    Bécuwe, P
    Krémarik-Bouillaud, P
    Domenjoud, L
    Keller, JM
    Schohn, H
    Dauça, M
    MICROSCOPY RESEARCH AND TECHNIQUE, 2003, 61 (02) : 185 - 190